Related Experiment Videos

Evidence that filopodia outgrowth is a common final pathway for fibroblast growth inhibition in vitro

B M Stanulis-Praeger1, M Yaar, B A Gilchrest

  • 1USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA.

Experimental Dermatology
|October 1, 1992
PubMed

Insights

Fibroblast growth inhibitors, interferon-alpha and all-trans retinoic acid, increase cell-cell contact via actin-dependent filopodia outgrowth. This suggests a mechanism for fibroblast growth restriction regardless of cause.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Dermatology

Background:

  • Fibroblast growth is crucial for tissue repair and development.
  • Understanding fibroblast growth regulation is key to treating fibrotic diseases.

Purpose of the Study:

  • To investigate the cellular events associated with fibroblast growth inhibition.
  • To examine the effects of interferon-alpha and all-trans retinoic acid on fibroblast morphology and growth.

Main Methods:

  • Cultured fibroblasts were treated with interferon-alpha or all-trans retinoic acid.
  • Cell growth rate, saturation density, and surface morphology were analyzed.
  • Intracellular filamentous actin and filopodia outgrowth were quantified over time.

Main Results:

  • Interferon-alpha reduced both fibroblast growth rate and saturation density.
  • All-trans retinoic acid reduced only fibroblast saturation density.
  • Both inhibitors increased filopodia outgrowth and intracellular filamentous actin, correlating with growth inhibition.

Conclusions:

  • Fibroblast growth restriction involves actin-dependent filopodia outgrowth.
  • Increased filopodia augment intercellular contact, contributing to growth inhibition.
  • This mechanism may be common across different causes of fibroblast growth restriction.

Related Concept Videos